Focus on:  Hide Contributions
Back to Conference View
Login
ICTR-PHE 2016

from Monday, February 15, 2016 (12:00 PM) to Friday, February 19, 2016 (3:40 PM)
Centre International de Conferences de Geneve (CICG)

        : Sessions
    /     : Talks
        : Breaks
Feb 15, 2016
Feb 16, 2016
Feb 17, 2016
Feb 18, 2016
Feb 19, 2016
AM
8:30 AM
Nuclear Medicine - Thomas Beyer Osman Ratib (until 10:00 AM) ()
8:30 AM Quantitative Theranostics in Nuclear Medicine - Michael Lassmann   (2)
9:00 AM Manufacturing and Nuclear Medicine Applications of the Novel Isotope Sn-117m - Nigel Stevenson   (2)
9:15 AM Contribution of direct and bystander effects to therapeutic efficacy of alpha-RIT using ²¹²Pb-labeled mAbs - Jean-Pierre Pouget   (2)
9:30 AM 64Cu-Labeled Folate Radioconjugate for PET Imaging of Folate Receptor-Positive Tumors - Renata Farkas   (2)
9:45 AM Radiolabeled Acridine Orange (AO) Derivatives as DNA-Targeted Probes for Auger Therapy - Antonio Paulo   ()
10:00 AM --- Coffee break ---
10:30 AM
Detectors & Imaging - Denis Dauvergne Alberto Del Guerra (until 2:15 PM) (2)
10:30 AM Imaging for online control of particle therapy - Thomas Bortfeld   (2)
11:00 AM First clinical application of a prompt gamma based in vivo proton range verification using a knife-edge slit camera - Christian Richter   (2)
11:30 AM New Results with Monolithic Scintillators for Time-of-Flight PET - Dennis Schaart   (2)
11:45 AM Development of a High Resolution Module for PET scanners - Gianluca Stringhini   (2)
12:00 PM J-PET: a novel TOF-PET scanner based on plastic scintillators - Pawel Moskal   (2)
12:15 PM Development of a radioguided surgery technique with beta- decays in brain tumor resection - Riccardo Faccini   (2)
12:30 PM --- Lunch ---
1:30 PM Range Verification with Ionoacoustics: simulations and measurements at a clinical proton synchro-cyclotron - Sebastian Lehrack   (2)
1:45 PM Measurement of Acoustic Emissions Generated by a Pulsed Proton Beam from a Hospital-Based Clinical Cyclotron - Kevin Jones   (2)
2:00 PM Fast Beam Profile Monitors for Microbeam Radiation Therapy - Bjarne Stugu   (2)
8:30 AM
ESTRO lecture - Yolande Lievens (until 9:00 AM) ()
8:30 AM How emerging trends in basic research & technology will shape clinical research? - Eric Deutsch   ()
9:00 AM
Plenary - Norman Coleman Ugo Amaldi (until 10:00 AM) (2)
9:00 AM Is Distributed learning the solution for Rapid Learning Health Care? - Philippe Lambin   (2)
9:30 AM Biological stratification in times of highly conformal radiotherapy - status and perspectives - Michael Baumann   (2)
10:00 AM --- Coffee and poster viewing ---
11:00 AM
Plenary - Norman Coleman Ugo Amaldi (until 12:00 PM) ()
11:00 AM Biological issues and their clinical implications in proton therapy - Radhe Mohan   ()
11:30 AM Single particle detection for spectroscopic CT and tracking in hadron therapy using Medipix chips - Michael Campbell   ()
8:15 AM
GH Fletcher Lecture - James Cox (until 8:50 AM) (2)
8:15 AM Multimodality Precision Medicine - Søren Bentzen   (2)
8:50 AM
Genomics - Simon Powell (until 10:05 AM) (3)
8:50 AM The search for genetic predictors of radiotherapy response - Dirk De Ruysscher   (3)
9:15 AM RSI: A genomic signature of radiosensitivity - Peter A. Johnstone   (3)
9:40 AM Radiomics in Liquid Biopsies - Frederic Zenhausern   (3)
8:50 AM
Panel discussion - Roberto Orecchia Vikram Bhadrasain (until 10:05 AM) (2)
8:50 AM Trials in USA - James Cox   (2)
9:15 AM Trials in Germany - Jürgen Debus   (2)
9:40 AM Clinical trials for carbon-ion radiotherapy in Japan - Hirohiko Tsujii   (2)
10:05 AM --- Coffee break ---
10:30 AM
EORTC session - Wilfried Budach Sofia Rivera (until 12:10 PM) (2)
10:30 AM Radiotherapy quality assurance platform of the EORTC - Damien Weber   (2)
10:52 AM Radiotherapy quality assurance platform of the EORTC - André Branquinho   (2)
11:02 AM Synergy of targeted agents and radiotherapy - Sofia Rivera   (2)
11:24 AM Lessons from translational research in EORTC Glioma trials - Monika Hegi   (2)
11:46 AM Data from the EORTC Cancer Survivorship Task Force - Conny Vrieling   (2)
10:30 AM
Proffered papers - Detectors and Imaging - Katia Parodi Paul Lecoq (until 11:45 AM) ()
10:30 AM Study of the radiation produced by therapeutic He, C and O ion beams impinging on a PMMA target - Alessio Sarti   (3)
10:45 AM Short-lived Positron Emitters in Beam-on PET ImagingDuring Proton Therapy - Tom Buitenhuis   (3)
11:00 AM DoPET: an in-treatment monitoring system for particle therapy - Valeria Rosso   (3)
11:15 AM Commissioning of a Compton camera for ion beam range verification via prompt gamma detection using low-energy and clinical particle beams - Saad Aldawood   (3)
11:30 AM Prompt Gamma-ray Timing experiment during different modalities of proton beam delivery - Thomas Kormoll   (3)
10:30 AM
Proffered papers - Radiobiology - Ulli Köster Mechthild Krause (until 12:00 PM) (4)
10:30 AM The effect of fractionated administration of thalidomide at γ-ray irradiation on tumor response and lung metastasis - Shin-ichiro Masunaga   (4)
10:45 AM Predictive Biomarkers for Improving Radiation Therapy - Pataje Prasanna   (4)
11:00 AM Targeted Radionuclide Therapy with 161Tb: Investigation of Anti-Tumor Effects and Undesired Side Effects - Cristina Müller   (4)
11:15 AM The relationship between absorbed dose and DNA Damage in Lymphocytes after radionuclide therapy - Uta Eberlein   (4)
11:30 AM Modeling the effect of symmetrical division of cancer stem cells on tumour response to radiation - Loredana Marcu   (4)
11:45 AM A dose response analysis of the patients treated with Boron Neutron Capture Therapy (BNCT) in Finland in 1999 to 2011 - Hanna Koivunoro   (4)
8:30 AM
Biomolecular mechanisms driving modulation of tumor cell sensitivity - Martin Pruschy Zvi Fuks (until 9:45 AM) ()
8:30 AM Genetic and pharmacological inhibition of autophagy after irradiation - Kasper Rouschop   (2)
8:55 AM Oncometabolite lactate promotes tumour growth - Pierre Sonveaux   (2)
9:20 AM Determining cell radiosensitivity using assays in ex vivo irradiated tumour specimens - Daniel Zips   (2)
8:30 AM
MEDICIS - PROMED program - Osman Ratib Thierry Stora (until 9:45 AM) (3)
8:30 AM MEDICIS-PROMED : a ITN Marie-Curie network on nuclear medicine and 11C-based hadron-therapy - Johanna Pitters   (3)
8:40 AM MEDICIS-PROMED: MEDICIS-Produced Radioisotope Beams for Medicine an Innovative Training Network - John Prior   (3)
9:05 AM Recurrent glioblastoma multiforme – targeted alpha therapy with 213Bi-DOTA-Substance P - Frank Bruchertseifer   (3)
9:25 AM Medical isotope production at TRIUMF and future collaboration with MEDICIS-PROMED - Yann Seimbille   (3)
8:30 AM
Oral poster presentation- Detectors and Imaging - Michael Campbell Mike Waligórski (until 9:40 AM) ()
8:30 AM Comparison of Arterial Input Functions by Magnitude and Phase Signal Measurement in DCE MRI of brain cancer patients - Catherine Coolens   (4)
8:40 AM Fast calibration of the range of Carbon ionswith in-beam PET of Boron-8 nuclei - Caterina Cuccagna   (4)
8:50 AM An online beam monitor detector for medical applications of ion beams - Saverio Braccini   (4)
9:00 AM The GEMPIX detector for energy deposition measurements in Hadrontherapy - Fabrizio Murtas   (4)
9:10 AM GPU based iterative CBCT for prospective motion compensated algorithm for radiation therapy - Ander Biguri   (4)
9:20 AM Measurements and simulations of in-phantom neutron dose from a proton pencil beam - Kristian Ytre-Hauge   (4)
9:30 AM CHIC – A Multi-scale Modelling Platform for in-silico Oncology - Daniel Abler   (4)
9:45 AM --- Coffee break ---
10:15 AM
Oral poster presentation - Miscellaneous - Jan Alsner Alessandra Bolsi (until 11:25 AM) (4)
10:15 AM Clinical validation of the M5L lung Computer-Assisted Detection system - Piergiorgio Cerello   (4)
10:25 AM Tuning of a 4D ML reconstruction strategy for treatment verification in ion beam radiotherapy - Katia Parodi   (4)
10:35 AM Differential cross sections measurements for hadrontherapy: 50 MeV/n 12C reactions on H, C, Al, O and natTi targets - Clovis Divay   (4)
10:45 AM Metal implanted multi-functional nanovectors for targeted radiotherapy and diagnostics of cancer - Asénath Etilé   (4)
10:55 AM The Malthus Project - updated predictions of national radiotherapy demand to 2030 - Thomas Mee   (4)
11:05 AM The use of radiobiological TCP and NTCP models to validate the dose calculation algorithm and readjust the prescribed dose - Jacques Balosso   (4)
11:15 AM Status of the CaLIPSO High-Resolution PET Project - Xavier Mancardi   (4)
10:15 AM
Oral poster presentation- Clinics - Esther Troost (until 11:25 AM) ()
10:15 AM The use of 149Tb and 152Tb in preclinical investigations: an update on its mass separation and subsequent application for imaging and therapy - Nicholas van der Meulen   (3)
10:25 AM Design of electronic data processing system for radiotherapy study: lessons learned from VoxTox - Marina Romanchikova   (3)
10:35 AM Assessment tool to quantify and visualize treatment plan robustness regarding patient setup - Michael Fix   (3)
10:45 AM A Hypercellular Component of Glioblastoma Identified by High b-value Diffusion Weighted Imaging - Yue Cao   (3)
10:55 AM Treatment of moving targets with active scanning carbon ion beams - Piero Fossati   (3)
11:05 AM Distributed learning: predictive models based on data from multiple hospitals without data leaving the hospital - Arthur Jochems   (3)
11:15 AM A clinical protocol for Simultaneous Integrated Boost for proton treatment of Head and Neck carcinoma - Francesca Belosi   (3)
10:15 AM
Panel discussion - Manjit Dosanjh Jens Overgaard (until 11:30 AM) (2)
10:15 AM Conceptual Design report for OpenMED - Ghislain Roy   (2)
10:40 AM OPENMED: Topics, Issues and Wishes - Mike Waligórski   (2)
11:05 AM Role of the CERN International Strategy Committee in the LEIR initiative: Biology - Philippe Lambin   (2)
11:30 AM --- Poster viewing ---
PM
1:00 PM Welcome address and opening - Jacques Bernier (GSMN) Manjit Dosanjh (CERN) Eckhard Elsen (CERN)   (2)
1:30 PM
Radiobiology - Kevin Prise Marco Durante (until 4:45 PM) ()
1:30 PM A comprehensive omics approach for development of prognostic or predictive biomarkers in squamous cell carcinoma of the head and neck treated with radiation - Michael Story   (2)
2:00 PM What are the Dominant Radiobiological Mechanisms at Play in Stereotactic Radiotherapy? - David Brenner   ()
2:30 PM The symbiosis of science of radiation biology with immunology: Impact on basic and translational research - Ahmed Mansoor   (2)
2:45 PM The relevance of DNA damage clustering on the nanometer and micrometer scale for the quantitative prediction of radiation effects - Michael Scholz   ()
3:00 PM Correlation of Particle Traversals with Clonogenic Survival Using Cell-Fluorescent Ion Track Hybrid Detector - Ivana Dokic   ()
3:15 PM Radiation induced DNA damage in human uveal melanoma cells - Katarzyna Jasińska   ()
3:30 PM --- Coffee break ---
4:00 PM Quantum dots imaging tests on SPAD for nanodosimetric applications - Alberto Quaranta   (2)
4:15 PM Disruption of telomere equilibrium sensitises human cancer cells to DNA repair inhibition and radiation - Prakash Hande   (2)
4:30 PM Investigating the impact of a variable RBE on proton dose fractionation across an actively scanned spread-out Bragg peak - Kevin Prise   (2)
4:45 PM
Nuclear Medicine - Thomas Beyer Osman Ratib (until 6:00 PM) ()
4:45 PM Molecular imaging for theranostics - Wim Oyen   (2)
5:15 PM Early variation of FDG-PET radiomics features in NSCLC is related to overall survival - the “delta radiomics” concept - Ralph Leijenaar   (2)
5:30 PM How to produce scandium-44 and scandium-43 efficiently? - Charlotte Duchemin Katharina Domnanich Jerzy Jastrzębski   (2)
2:15 PM
New Technologies - Hans-Peter Meinzer Wolfgang Enghardt (until 3:45 PM) ()
2:15 PM MRI for external beam radiotherapy guidance - Jan Lagendijk   (2)
2:45 PM MRI Guided Proton Therapy: pencil beam scanning in an MRI fringe field - Brad Oborn   (2)
3:00 PM Nanoparticle Enhanced MRI-Guided Radiation Therapy: Final proof of concept before phase I trial - Shady Kotb   (2)
3:15 PM Hadron minibeam radiation therapy: feasibility study at the Heidelberg IonBeam Therapy Center (HIT) - Immaculada Martínez-Rovira   (2)
3:30 PM Evaluation of long-term effects of synchrotron-generated microbeams on rat hippocampal neurogenesis - Alberto Bravin   (2)
3:45 PM --- Coffee Break ---
4:15 PM
New Technologies - Wolfgang Enghardt Hans-Peter Meinzer (until 5:30 PM) ()
4:15 PM Big Data in Radiation Oncology: data gathering, data processing, algorithms and clinical impact - Klaus Maier-Hein   ()
4:45 PM Expert knowledge and data-driven Bayesian Networks to predict post-RT dyspnea and 2-year survival - Timo Deist   (2)
5:00 PM Dosimetry of ultra high dose rate irradiation for studies on the biological effect induced in normal brain and GBM - Kristoffer Petersson   (2)
5:15 PM Geant4 coupled with Comsol heat transfer simulations to determine correction factors of a novel micro-calorimeter - Kamran Fathi   ()
6:30 PM Public talk - Sound for Health - Domenico Vicinanza - Domenico Vicinanza   (2)
12:00 PM --- Lunch & Exhibitor presentations ---
1:00 PM
Novel approaches in imaging - Philippe Lambin (until 2:15 PM) (2)
1:00 PM New hypoxia probe development based on mass spectrometry - Brad Wouters   (2)
1:25 PM The role of functional imaging for radiation oncology – The whole translational chain from animals to clinics - Esther Troost   (2)
1:50 PM Is dual energy CT the next standard imaging modality for radiotherapy? - Wouter van Elmpt   (2)
1:00 PM
Particle therapy (I) - Hirohiko Tsujii Jürgen Debus (until 2:15 PM) (3)
1:00 PM Proton Radiation Therapy: Current Status at Massachusetts General Hospital - Thomas DeLaney   (3)
1:25 PM MedAustron - status and vision - Eugen Hug   (3)
1:50 PM Particle therapy centre in Shanghai - Zhen Zhang   (3)
1:00 PM
Proffered papers- clinical - Carlo Greco (until 2:15 PM) (4)
1:00 PM Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect - Thomas Zilli   (4)
1:15 PM A novel method to predict a priori the toxicity reduction of a prostate-rectum spacer: Virtual Rectum Spacer - Ben Vanneste   (4)
1:30 PM Local Tumor Flare Following Radiosurgery and Ipilimumab (Ipi) for Melanoma Brain Metastases: Increased Immune Response? - Caroline Chung   (4)
1:45 PM Response-based Bayesian Network Approaches for Adaptive Radiotherapy of Non-Small Cell Lung Cancer (NSCLC) - Randall Ten Haken   (4)
2:00 PM Further Development of Spinal Tissue Radiotherapy Re-treatment Modelling, with inclusion of Hadrontherapy - Bleddyn Jones   (4)
2:15 PM
Oral poster presentation- Physics/Biology - Dag-Rune Olsen (until 3:45 PM) (4)
2:15 PM Proton Minibeam Radiation Therapy (pMBRT): implementation at a clinical center - Cécile Peucelle   (4)
2:25 PM Investigation of the use of inhomogeneous fractional dose distributions in IMPT to improve the therapeutic index - Lorenzo Manganaro   (4)
2:35 PM Accuracy of portal dosimetry in hybrid IMRT and VMAT treatment of the prostate - James Bedford   (4)
2:45 PM ODSH as a countermeasure for radiation-induced thrombocytopenia: Dosimetric studies - Stephen Avery   (4)
2:55 PM Measurements of Reactive Oxygen Species production induced by Gold Nanoparticles in Radiotherapy protoco - Piergiorgio Cerello   (4)
3:05 PM NanoxTM: A new multiscale theoretical framework to predict cell survival in the context of particle therapy - Micaela Cunha   (4)
3:15 PM Simulation of cell survival for proton broad and minibeam radiotherapy with hexagonal and square minibeam alignment - Matthias Sammer   (4)
3:25 PM Microbeam Radiation Therapy (MRT): achievements and future perspectives - Elke Bräuer-Krisch   (4)
3:35 PM The role of adipose stromal cells for reversal of radiation fibrosis - Fei-Fei Liu   (4)
2:15 PM
Panel discussion - Hans Langendijk Søren Bentzen (until 3:55 PM) (3)
2:15 PM Current and future strategies developed at Paul Scherrer Institute - Alessandra Bolsi   (3)
2:40 PM Optimizing prostate cancer irradiation: from technology to fractionation - Raymond Miralbell   (3)
3:05 PM Technological advancement in radiation oncology - Hak Choy   (3)
3:30 PM Main challenges in adaptive radiotherapy - Jan-Jakob Sonke   (3)
2:15 PM
Panel discussion - Karin Haustermans (until 3:55 PM) (2)
2:15 PM The Biology of Single Dose Radiotherapy - Zvi Fuks   (2)
2:40 PM Are there common signaling pathways among highly radioresistant tumors? The examples of high grade gliomas and sarcomas - Elizabeth Moyal   (2)
3:05 PM HIF-related therapeutic windows - Amato Giaccia   (2)
3:30 PM Vascular disrupting agents: a new avenue of research - Michael Horsman   (2)
3:55 PM --- Coffee break ---
4:30 PM
Novel strategies to overcome cancer (I): Immunology-based attacks - Marce Verheij (until 5:45 PM) (2)
4:30 PM Oncolytic viruses - Kevin Harrington   (2)
4:55 PM Synergy of radiotherapy and cancer vaccines in HPV-positive tumors - Eric Deutsch   (2)
5:20 PM Radiotherapy and the immunocytokine L19-IL2: a perfect match for an abscopal effect with long-lasting memory - Ludwig Dubois   (2)
4:30 PM
Novel strategies to overcome cancer (II): Enhancing the ratio between tumor cell killing and normal tissue protection - Raymond Miralbell (until 5:45 PM) (3)
4:30 PM Pelvic tumor irradiation: new tools to reduce toxicity: from technology to drugs - Karin Haustermans   (3)
4:55 PM Towards a new type of irradiation - Jean Bourhis   (3)
5:20 PM Treatment outcome in patients treated with single-dose irradiation (SDRT) for oligometastatic disease - Carlo Greco   (2)
4:30 PM
Proffered papers - Emerging technologies - Vincenzo Patera Marco Silari (until 5:45 PM) (4)
4:30 PM Geometrical interpretation of TOF PET raw data in commercial PET-CT scanner for SNR optimization - Chiara Gianoli   (4)
4:45 PM Characterization and test beam results of a LaBr3 Compton Telescope for treatment monitoring - Gabriela Llosá   (4)
5:00 PM Small Large Momentum Acceptance Gantries for Proton and Carbon Cancer Therapy - Dejan Trbojevic   (4)
5:15 PM X-Ray Phase contrast micro-imaging in neuroscience - Giacomo Barbone   (4)
5:30 PM Water based 3D optical dose imaging for particle therapy - Oksana Kavatsyuk   (4)
7:00 PM --- Gala dinner with Keynote by Vytenis Andriukaitis, EC Health Commissioner ---
12:00 PM
Lunch & Start-up presentations (until 1:00 PM) ()
1:00 PM
European School of Oncology - E. van der Schueren Award - Fedro Peccatori (until 1:30 PM) (2)
1:00 PM Tackling Phenotypic Diversity to Increase Cures - Brad Wouters   (2)
1:30 PM
Novel strategies to overcome cancer: Tumor cell radiosensitivity modulation - Jacques Bernier Jean Bourhis (until 2:45 PM) (3)
1:30 PM Novel anti-tumor agents targeting cell membrane - Marcel Verheij   (3)
1:55 PM Stroma mediated wound healing signals and cell response to radiation - Marie-Catherine Vozenin   (3)
2:20 PM Targeting tumor heterogeneity - Gerben Borst   (3)
1:30 PM
Proffered papers - Physics - Thomas Bortfeld (until 2:45 PM) ()
1:30 PM Towards analytic dose calculation for MR guided particle beam therapy - Hermann Fuchs   (4)
1:45 PM Experimental dosimetric comparisons of protons, helium, carbon and oxygen ion beams - Thomas Tessonnier   (4)
2:00 PM Implementation of an analytical solution to lateral dose prediction in a proton therapy treatment planning system - Valentina Elettra Bellinzona   (4)
2:15 PM Utilizing CBCT data for dose calculation in adaptive IMPT - Christopher Kurz   (4)
2:30 PM Can we replace high quality simulation CT by simple kV-cone-beam CT images to extract an externally validated radiomics signature? - Janita van Timmeren   (4)
1:30 PM
Revisiting RBE - Jens Overgaard (until 2:45 PM) (2)
1:30 PM In-vitro RBE - Marco Durante   (2)
1:55 PM Carbon ion radiotherapy: do we understand each other? How to compare differentt RBE-weighted dose systems in the clinical setting - Piero Fossati   (2)
2:20 PM Physics and RBE - Tony Lomax   (2)
2:45 PM --- Coffee and poster viewing ---
4:15 PM
Emerging challenges in combating cancer - Vincent Grégoire (until 5:30 PM) (3)
4:15 PM Emerging challenges in combating cancer - Norman Coleman   (3)
4:40 PM Targeted Treatment for the Non- Small Cell Lung Cancer - Ritsuko Komaki   (3)
5:05 PM Magnetic resonance temperature imaging in clinical hyperthermia: past experience and prospects - Peter Wust   (3)
4:15 PM
Particle therapy (II) - Jacques Balosso Damien Weber (until 5:30 PM) (2)
4:15 PM Current status of particle therapy at CNAO - Roberto Orecchia   (2)
4:40 PM Integration of economic data in clinical trials - Yolande Lievens   (2)
5:05 PM Current status of particle therapy in The Netherlands - Hans Langendijk   (2)
4:15 PM
Proffered papers -Biology - Michael Horsman Amato Giaccia (until 5:30 PM) (4)
4:15 PM Radiation treatment monitoring using multifunctional imaging in prostate tumour xenografts - Natalia Arteaga-Marrero   (4)
4:30 PM Robustness and reliability of PET-based identification and quantification of tumor hypoxia, using simple static or more complex scan acquisitions - Morten Busk   (4)
4:45 PM Variable RBE in proton therapy: comparison of model predictions and their impact on clinical-like cranial lesions - Julia Bauer   (4)
5:00 PM Inhibiting the actions of cathepsin L effects both tumour initiation and metastasis formation - Thomas Wittenborn   (4)
5:15 PM Plerixafor Improves Local Control and Reduces Metastases in Cervical Cancer Treated with Radiotherapy and Chemotherapy - Michael Milosevic   (4)
12:00 PM --- Lunch ---
12:45 PM
Panel discussion - Daniel Zips (until 2:00 PM) (2)
12:45 PM Multimodal approach to assess tumour vasculature and potential treatment effect - Dag Rune Olsen   (2)
1:10 PM Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma - Vincent Gregoire   (2)
1:35 PM Microtubule-stabilizing agents with inhibitors of angiogenesis to overcome resistance - Martin Pruschy   (2)
12:45 PM
Preclinical models - Richard Kolesnick (until 2:00 PM) (3)
12:45 PM Orthotopic tumor models for glioma and NSCLC - Jan Theys   (3)
1:10 PM High Performance Preclinical Irradiation Through Optimized Dual Focal Spot Dose Painting and Online Virtual Isocenter Radiation Field Targeting - David Jaffray   (3)
1:35 PM Studying radiotherapy resistance of BRCA1-mutated mammary tumors - Sven Rottenberg   (2)
12:45 PM
Winning posters - Jacques Bernier Manjit Dosanjh (until 2:00 PM) ()
2:00 PM
Modulating response to radiation - Elizabeth Moyal (until 3:15 PM) (3)
2:00 PM Balanced checkpoint activation: genomic stability and cell response to radiation - Simon Powell   (3)
2:25 PM Macrophage reprogramming for anticancer therapy - Michele De Palma   (3)
2:50 PM Focal adhesion signaling and therapy resistance in cancer - Anne Vehlow   (3)
2:00 PM
Research seminar:Overcoming cancer radioresistance - Brad Wouters (until 3:15 PM) ()
2:00 PM Factors of radioresistance in prostate cancer - Mechthild Krause   (2)
2:25 PM Targeting NOTCH pathway in Glioblastoma - Marc Vooijs   (2)
2:50 PM Human Sphingolipid Biomarkers of Single Dose Radiotherapy: A Clinical trial - Richard Kolesnick   (2)
3:15 PM
Concluding remarks - Jacques Bernier Manjit Dosanjh (until 3:40 PM) (2)
Powered by Indico v3.2.5-pre